Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Get guidance on which passive funds to buy for retirement, focusing on cost, diversification, and long-term goals.
24,385 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
A new analysis shows Microsoft’s AI-driven revenue pace hitting fresh highs, suggesting meaningful upside for patient...
Want to protect cash flow while staying on the right side of the law? This guide shows real estate investors legally ...
Three candidates backed by mayor zohran mamdani ‘better won key NYC primaries, expanding the left-leaning bloc and si...
A sweeping shift is reshaping the auto industry. Here are two compelling reasons this massive global turnaround could...
Investing in homebuilders can be fast-moving. This article explains why a home stock jumped today, the catalysts behi...
Bitcoin slipped below the $59,000 level for the first time in almost two years, intensifying a risk-off mood as Micro...
June data show a surge in miner deposits to Binance, with inflows eclipsing 150,000 BTC and marking a four-month peak...
As of Jun 26, 2026, major tokens face renewed pressure with ETH and XRP testing critical supports while ADA and BNB s...
Apple stock just dropped as memory costs surge and device pricing shifts bite into margins. Traders weigh supply-chai...
Software stocks climbed on renewed investor optimism as fears about OpenAI-driven disruption cooled. ServiceNow and S...
SpaceX's Starlink program could redefine internet access and investor value. This year’s launch pace hinges on regula...